Literature DB >> 18805107

Epidemiology, heritability, and genetic linkage of C-reactive protein in African Americans (from the Jackson Heart Study).

Ervin R Fox1, Emelia J Benjamin, Daniel F Sarpong, Charles N Rotimi, James G Wilson, Michael W Steffes, Guanjie Chen, Adebowale Adeyemo, Jason K Taylor, Tandaw E Samdarshi, Herman A Taylor.   

Abstract

C-reactive protein (CRP) has been studied largely in white non-Hispanic cohorts. There is limited information on CRP's range of values, heritability, and relation to cardiovascular disease risk factors in African Americans. The aim of this study was to evaluate the distribution, clinical correlates, heritability, and genetic linkage of log-transformed CRP in participants in the middle-aged to elderly African American cohort in the community-based Jackson Heart Study. The distribution and correlates of CRP were analyzed for the entire study cohort who underwent the first examination (2001 to 2004). Heritability was estimated for the family cohort nested within the larger Jackson Heart Study (246 families, n = 1,317). The relation between CRP and cardiovascular disease risk factors was tested with multivariable stepwise regression analyses. Heritability was estimated using a variance-components method. Linkage analysis was performed using the multipoint variance-components approach. The study sample consisted of 4,919 participants (mean age 55 +/- 13 years, 63% women); the median CRP concentration was 2.7 mg/L. In stepwise models, traditional risk factors explained 23.8% of CRP's variability, with body mass index (partial R(2) = 13.6%) explaining 57.1% of the variability of CRP due to traditional risk factors. The heritability of CRP (adjusted for age, gender, and body mass index) was 0.45. The strongest linkage evidence for CRP was observed on chromosome 11 (11p13 to 11p11.2), with a logarithm of odds score of 2.72. In conclusion, in this large population-based cohort of African Americans, circulating CRP concentration was heritable and associated with several traditional cardiovascular risk factors, particularly body mass index.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18805107      PMCID: PMC3733442          DOI: 10.1016/j.amjcard.2008.05.049

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  28 in total

1.  Genome scan of systemic biomarkers of vascular inflammation in the Framingham Heart Study: evidence for susceptibility loci on 1q.

Authors:  Josée Dupuis; Martin G Larson; Ramachandran S Vasan; Joseph M Massaro; Peter W F Wilson; Izabella Lipinska; Diane Corey; Joseph A Vita; John F Keaney; Emelia J Benjamin
Journal:  Atherosclerosis       Date:  2005-03-24       Impact factor: 5.162

2.  Recruiting African-American research participation in the Jackson Heart Study: methods, response rates, and sample description.

Authors:  Sonja R Fuqua; Sharon B Wyatt; Michael E Andrew; Daniel F Sarpong; Frances R Henderson; Margie F Cunningham; Herman A Taylor
Journal:  Ethn Dis       Date:  2005       Impact factor: 1.847

3.  Study design for genetic analysis in the Jackson Heart Study.

Authors:  James G Wilson; Charles N Rotimi; Lynette Ekunwe; Charmaine D M Royal; Mary E Crump; Sharon B Wyatt; Michael W Steffes; Adebowale Adeyemo; Jie Zhou; Herman A Taylor; Cashell Jaquish
Journal:  Ethn Dis       Date:  2005       Impact factor: 1.847

4.  C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992.

Authors:  W Koenig; M Sund; M Fröhlich; H G Fischer; H Löwel; A Döring; W L Hutchinson; M B Pepys
Journal:  Circulation       Date:  1999-01-19       Impact factor: 29.690

5.  Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study.

Authors:  J S Pankow; A R Folsom; M Cushman; I B Borecki; P N Hopkins; J H Eckfeldt; R P Tracy
Journal:  Atherosclerosis       Date:  2001-02-15       Impact factor: 5.162

6.  Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects.

Authors:  R P Tracy; B M Psaty; E Macy; E G Bovill; M Cushman; E S Cornell; L H Kuller
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-10       Impact factor: 8.311

7.  The influence of age, sex, and race on the upper reference limit of serum C-reactive protein concentration.

Authors:  M H Wener; P R Daum; G M McQuillan
Journal:  J Rheumatol       Date:  2000-10       Impact factor: 4.666

8.  Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events.

Authors:  Leslie A Lange; Christopher S Carlson; Lucia A Hindorff; Ethan M Lange; Jeremy Walston; J Peter Durda; Mary Cushman; Joshua C Bis; Donglin Zeng; Danyu Lin; Lewis H Kuller; Deborah A Nickerson; Bruce M Psaty; Russell P Tracy; Alexander P Reiner
Journal:  JAMA       Date:  2006-12-13       Impact factor: 56.272

9.  Contribution of clinical correlates and 13 C-reactive protein gene polymorphisms to interindividual variability in serum C-reactive protein level.

Authors:  Sekar Kathiresan; Martin G Larson; Ramachandran S Vasan; Chao-Yu Guo; Philimon Gona; John F Keaney; Peter W F Wilson; Christopher Newton-Cheh; Stacy L Musone; Amy L Camargo; Jared A Drake; Daniel Levy; Christopher J O'Donnell; Joel N Hirschhorn; Emelia J Benjamin
Journal:  Circulation       Date:  2006-03-13       Impact factor: 29.690

10.  C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction.

Authors:  P M Ridker; R J Glynn; C H Hennekens
Journal:  Circulation       Date:  1998-05-26       Impact factor: 29.690

View more
  35 in total

1.  C-reactive protein and subclinical cardiovascular disease among African-Americans: (the Jackson Heart Study).

Authors:  Jung Hye Sung; Jae Eun Lee; Tandaw E Samdarshi; Harsha S Nagarajarao; Jason K Taylor; Khushboo K Agrawal; Herman A Taylor; Ervin R Fox
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2014-05       Impact factor: 2.160

Review 2.  Genetic insights into cardiometabolic risk factors.

Authors:  John B Whitfield
Journal:  Clin Biochem Rev       Date:  2014-02

3.  Shared genetic susceptibility of vascular-related biomarkers with ischemic and recurrent stroke.

Authors:  Stephen R Williams; Fang-Chi Hsu; Keith L Keene; Wei-Min Chen; Sarah Nelson; Andrew M Southerland; Ebony B Madden; Bruce Coull; Stephanie M Gogarten; Karen L Furie; Godfrey Dzhivhuho; Joe L Rowles; Prachi Mehndiratta; Rainer Malik; Josée Dupuis; Honghuang Lin; Sudha Seshadri; Stephen S Rich; Michèle M Sale; Bradford B Worrall
Journal:  Neurology       Date:  2015-12-30       Impact factor: 9.910

Review 4.  Monitoring of inflammation in patients on dialysis: forewarned is forearmed.

Authors:  Christiaan L Meuwese; Peter Stenvinkel; Friedo W Dekker; Juan J Carrero
Journal:  Nat Rev Nephrol       Date:  2011-03       Impact factor: 28.314

5.  Perceived Discrimination and Cardiovascular Outcomes in Older African Americans: Insights From the Jackson Heart Study.

Authors:  Shannon M Dunlay; Steven J Lippmann; Melissa A Greiner; Emily C O'Brien; Alanna M Chamberlain; Robert J Mentz; Mario Sims
Journal:  Mayo Clin Proc       Date:  2017-05       Impact factor: 7.616

6.  Genome-wide association and population genetic analysis of C-reactive protein in African American and Hispanic American women.

Authors:  Alex P Reiner; Sandra Beleza; Nora Franceschini; Paul L Auer; Jennifer G Robinson; Charles Kooperberg; Ulrike Peters; Hua Tang
Journal:  Am J Hum Genet       Date:  2012-08-30       Impact factor: 11.025

7.  Familial aggregation of circulating C-reactive protein in polycystic ovary syndrome.

Authors:  Arunachalam Sasidevi; Priyathama Vellanki; Allen R Kunselman; Nazia Raja-Khan; Andrea Dunaif; Richard S Legro
Journal:  Hum Reprod       Date:  2012-12-20       Impact factor: 6.918

8.  Ox-LDL upregulates CRP expression through the IGF2 pathway in THP-1 macrophages.

Authors:  Shu-Fen Li; Yan-Wei Hu; Jia-Yi Zhao; Xin Ma; Shao-Guo Wu; Jing-Bo Lu; Ya-Rong Hu; Yan-Chao Wang; Ji-Juan Gao; Yan-Hua Sha; Lei Zheng; Qian Wang
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

Review 9.  The effect of angiotensin receptor blockers on C-reactive protein and other circulating inflammatory indices in man.

Authors:  Alessandra Del Fiorentino; Silvana Cianchetti; Alessandro Celi; Giulia Dell'Omo; Roberto Pedrinelli
Journal:  Vasc Health Risk Manag       Date:  2009-04-08

10.  The relation of C--reactive protein to chronic kidney disease in African Americans: the Jackson Heart Study.

Authors:  Ervin R Fox; Emelia J Benjamin; Daniel F Sarpong; Harsha Nagarajarao; Jason K Taylor; Michael W Steffes; Abdullah K Salahudeen; Michael F Flessner; Ermeg L Akylbekova; Caroline S Fox; Robert J Garrison; Herman A Taylor
Journal:  BMC Nephrol       Date:  2010-01-15       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.